Salvia plebeia R.Br. inhibits signal transduction of IL-6 and prevents ovariectomy-induced bone loss by suppressing osteoclastogenesis

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis

(2016) Arthur Kavanaugh   Therapeutics and Clinical Risk Management

Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis

(2015) Kyoung-Woon Kim et al.   ARTHRITIS RESEARCH & THERAPY

Salvia plebeia Suppresses Atopic Dermatitis-Like Skin Lesions

(2014) Jin Kyeong Choi et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Four new eudesmane-type sesquiterpenes from the basal leaves of Salvia plebeia R. Br.

(2014) Yiqun Dai et al.   FITOTERAPIA

RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis

(2014) Susan Li et al.   JOURNAL OF CLINICAL INVESTIGATION

AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis

(2013) Chang-hong Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice

(2013) Sun-Don Kim et al.   BIOCHEMICAL PHARMACOLOGY

The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss

(2013) Masahiro Shinohara et al.   BONE

Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways

(2013) Manoj Nepal et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Polyphenol Fisetin Protects Bone by Repressing NF-κB and MKP-1-Dependent Signaling Pathways in Osteoclasts

(2013) Laurent Léotoing et al.   PLoS One

Vigna angularis inhibits IL-6-induced cellular signalling and ameliorates collagen-induced arthritis

(2013) Hyun-Mee Oh et al.   RHEUMATOLOGY

Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos

(2012) Long He et al.   BONE

Alternative therapies for the prevention and treatment of osteoporosis

(2012) Jameela Banu et al.   NUTRITION REVIEWS

RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation

(2011) Jung Ha Kim et al.   BIOCHEMICAL JOURNAL

Manassantin A and B From Saururus chinensis Inhibit Interleukin-6–Induced Signal Transducer and Activator of Transcription 3 Activation in Hep3B Cells

(2011) Jong Sun Chang et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Inhibitory effect of luteolin on osteoclast differentiation and function

(2010) Ji-Won Lee et al.   CYTOTECHNOLOGY

Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis

(2010) Benoit Le Goff et al.   JOINT BONE SPINE

The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss

(2010) Tae-Ho Kim et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

RANK/RANKL: Regulators of Immune Responses and Bone Physiology

(2009) Andreas Leibbrandt et al.   Annals of the New York Academy of Sciences

IL-6 receptor expression and IL-6 effects change during osteoblast differentiation

(2008) Yan Li et al.   CYTOKINE

Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways

(2008) Fumio Yoshitake et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemical fingerprint and quantitative analysis of Salvia plebeia R.Br. by high-performance liquid chromatography

(2008) Xiao-feng Jin et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Differentiation of Osteoblasts and Osteocytes from Mesenchymal Stem Cells

(2008) Terhi Heino et al.   Current Stem Cell Research & Therapy